AD Drug development to target Ab or tau

*MAb: monoclonal antibody, **Clinical trial (s) was failed. See the text.
Exp Neurobiol 2010;19:120~131 https://doi.org/10.5607/en.2010.19.3.120
© Exp Neurobiol
© 2019. The Korean Society for Brain and Neural Sciences. / Powered by INFOrang Co., Ltd